The surgery dates for my group ranged from May 2001 to Sept. 2012 so all of my group would be in the Italian post 1999 group. Of the 25, 3 had neoadjuvant chemo before the resection and I don't have information regarding if they had chemo after the resection. Of the others, 15 had adjuvant or systemic therapy, 6 had none, and 1 was not available.
My database at this time represents only 8% of the foundation's membership. Considering that the total membership at this time is 2,339, the potential number of members falling into this classification could conceivably be over 300, although it probably won't be that high since I have been concentrating so far, but not exclusively, on finding members with IHCC.
However, the paper by Olivier Farges, which discussed preliminary analysis of the AJCC 7th edition of TMN Staging for resectable IHCC, used a cohort of 163 patients and the median survival for the entire cohort was 36 months. His study started with 522 patients but excluded 217 of them because of no lymphadenectory, 63 because of no accurate pN staging, 63 because of no R0 resenction, and 16 for other causes. Of the 25 in my database, 15 are R0, 5 appear to be R0, 1 is R1, 2 are R2, and 1 is unknown. So the 25 member cohort should have a lower survival rate than the Farges paper. It's not, but the 37.4 months I got was pretty close to the 36 months that Farges got.
Bruce
Please be advised that any advice or information in my posts is my personal opinion only and is not intended nor implied to be a substitute for professional medical advice. ALWAYS seek the advice of your physician or other qualified health care provider.